OncoNano Medicine, Inc. — Form D

OncoNano Medicine, Inc. of Southlake, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-28. The offering totals $11.7M, of which $11.7M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2018-03-28
• Form: D
• Accession: 0001735726-18-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $11.7M
• Amount sold: $11.7M
• Investors: 27
• Date of first sale: 2018-03-13
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-308806

Issuer

• Name: OncoNano Medicine, Inc.
• CIK: 0001735726
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 550 Reserve Street Suite 190, Southlake, TX, 76092
• Phone: (682) 712-1581

Officers, directors & promoters (25)

Other filings by this issuer (6)

More

• CIK 1735726 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search